Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 41

1.

Non-diffracting beams for label-free imaging through turbid media.

Nagar H, Dekel E, Kasimov D, Roichman Y.

Opt Lett. 2018 Jan 15;43(2):190-193. doi: 10.1364/OL.43.000190.

PMID:
29328235
2.

Prediction of multidimensional drug dose responses based on measurements of drug pairs.

Zimmer A, Katzir I, Dekel E, Mayo AE, Alon U.

Proc Natl Acad Sci U S A. 2016 Sep 13;113(37):10442-7. doi: 10.1073/pnas.1606301113. Epub 2016 Aug 25.

3.

Identification and classification of the malaria parasite blood developmental stages, using imaging flow cytometry.

Dekel E, Rivkin A, Heidenreich M, Nadav Y, Ofir-Birin Y, Porat Z, Regev-Rudzki N.

Methods. 2017 Jan 1;112:157-166. doi: 10.1016/j.ymeth.2016.06.021. Epub 2016 Jun 25.

PMID:
27350362
4.

Glucose becomes one of the worst carbon sources for E.coli on poor nitrogen sources due to suboptimal levels of cAMP.

Bren A, Park JO, Towbin BD, Dekel E, Rabinowitz JD, Alon U.

Sci Rep. 2016 Apr 25;6:24834. doi: 10.1038/srep24834.

5.

Dynamics inside the cancer cell attractor reveal cell heterogeneity, limits of stability, and escape.

Li Q, Wennborg A, Aurell E, Dekel E, Zou JZ, Xu Y, Huang S, Ernberg I.

Proc Natl Acad Sci U S A. 2016 Mar 8;113(10):2672-7. doi: 10.1073/pnas.1519210113. Epub 2016 Feb 29.

6.

Hierarchy of non-glucose sugars in Escherichia coli.

Aidelberg G, Towbin BD, Rothschild D, Dekel E, Bren A, Alon U.

BMC Syst Biol. 2014 Dec 24;8:133. doi: 10.1186/s12918-014-0133-z.

7.

Linear superposition and prediction of bacterial promoter activity dynamics in complex conditions.

Rothschild D, Dekel E, Hausser J, Bren A, Aidelberg G, Szekely P, Alon U.

PLoS Comput Biol. 2014 May 8;10(5):e1003602. doi: 10.1371/journal.pcbi.1003602. eCollection 2014 May.

8.

Promoter activity dynamics in the lag phase of Escherichia coli.

Madar D, Dekel E, Bren A, Zimmer A, Porat Z, Alon U.

BMC Syst Biol. 2013 Dec 30;7:136. doi: 10.1186/1752-0509-7-136.

9.

Promoters maintain their relative activity levels under different growth conditions.

Keren L, Zackay O, Lotan-Pompan M, Barenholz U, Dekel E, Sasson V, Aidelberg G, Bren A, Zeevi D, Weinberger A, Alon U, Milo R, Segal E.

Mol Syst Biol. 2013 Oct 29;9:701. doi: 10.1038/msb.2013.59.

10.

Response to comment on "Evolutionary trade-offs, Pareto optimality, and the geometry of phenotype space".

Shoval O, Sheftel H, Shinar G, Hart Y, Ramote O, Mayo A, Dekel E, Kavanagh K, Alon U.

Science. 2013 Feb 15;339(6121):757. doi: 10.1126/science.1228921.

PMID:
23413339
11.

Mutant p53 attenuates the anti-tumorigenic activity of fibroblasts-secreted interferon beta.

Madar S, Harel E, Goldstein I, Stein Y, Kogan-Sakin I, Kamer I, Solomon H, Dekel E, Tal P, Goldfinger N, Friedlander G, Rotter V.

PLoS One. 2013 Apr 22;8(4):e61353. doi: 10.1371/journal.pone.0061353. Print 2013.

12.

The last generation of bacterial growth in limiting nutrient.

Bren A, Hart Y, Dekel E, Koster D, Alon U.

BMC Syst Biol. 2013 Mar 25;7:27. doi: 10.1186/1752-0509-7-27.

13.

p53 counteracts reprogramming by inhibiting mesenchymal-to-epithelial transition.

Brosh R, Assia-Alroy Y, Molchadsky A, Bornstein C, Dekel E, Madar S, Shetzer Y, Rivlin N, Goldfinger N, Sarig R, Rotter V.

Cell Death Differ. 2013 Feb;20(2):312-20. doi: 10.1038/cdd.2012.125. Epub 2012 Sep 21.

14.

Mutant p53R273H attenuates the expression of phase 2 detoxifying enzymes and promotes the survival of cells with high levels of reactive oxygen species.

Kalo E, Kogan-Sakin I, Solomon H, Bar-Nathan E, Shay M, Shetzer Y, Dekel E, Goldfinger N, Buganim Y, Stambolsky P, Goldstein I, Madar S, Rotter V.

J Cell Sci. 2012 Nov 15;125(Pt 22):5578-86. doi: 10.1242/jcs.106815. Epub 2012 Aug 16.

15.

Mode of regulation and the insulation of bacterial gene expression.

Sasson V, Shachrai I, Bren A, Dekel E, Alon U.

Mol Cell. 2012 May 25;46(4):399-407. doi: 10.1016/j.molcel.2012.04.032.

16.

Evolutionary trade-offs, Pareto optimality, and the geometry of phenotype space.

Shoval O, Sheftel H, Shinar G, Hart Y, Ramote O, Mayo A, Dekel E, Kavanagh K, Alon U.

Science. 2012 Jun 1;336(6085):1157-60. doi: 10.1126/science.1217405. Epub 2012 Apr 26.

17.

Using bleach-chase to measure protein half-lives in living cells.

Geva-Zatorsky N, Issaeva I, Mayo A, Cohen A, Dekel E, Danon T, Cohen L, Liron Y, Alon U, Eden E.

Nat Protoc. 2012 Mar 29;7(4):801-11. doi: 10.1038/nprot.2012.028.

PMID:
22461069
18.

The mirror game as a paradigm for studying the dynamics of two people improvising motion together.

Noy L, Dekel E, Alon U.

Proc Natl Acad Sci U S A. 2011 Dec 27;108(52):20947-52. doi: 10.1073/pnas.1108155108. Epub 2011 Dec 12.

19.

Cell-to-cell spread of HIV permits ongoing replication despite antiretroviral therapy.

Sigal A, Kim JT, Balazs AB, Dekel E, Mayo A, Milo R, Baltimore D.

Nature. 2011 Aug 17;477(7362):95-8. doi: 10.1038/nature10347.

PMID:
21849975
20.

Negative auto-regulation increases the input dynamic-range of the arabinose system of Escherichia coli.

Madar D, Dekel E, Bren A, Alon U.

BMC Syst Biol. 2011 Jul 12;5:111. doi: 10.1186/1752-0509-5-111.

21.

Proteome half-life dynamics in living human cells.

Eden E, Geva-Zatorsky N, Issaeva I, Cohen A, Dekel E, Danon T, Cohen L, Mayo A, Alon U.

Science. 2011 Feb 11;331(6018):764-8. doi: 10.1126/science.1199784. Epub 2011 Jan 13.

22.

Fourier analysis and systems identification of the p53 feedback loop.

Geva-Zatorsky N, Dekel E, Batchelor E, Lahav G, Alon U.

Proc Natl Acad Sci U S A. 2010 Jul 27;107(30):13550-5. doi: 10.1073/pnas.1001107107. Epub 2010 Jul 9.

23.

Validation of an ambulatory cough detection and counting application using voluntary cough under different conditions.

Vizel E, Yigla M, Goryachev Y, Dekel E, Felis V, Levi H, Kroin I, Godfrey S, Gavriely N.

Cough. 2010 May 27;6:3. doi: 10.1186/1745-9974-6-3.

24.

Cost of unneeded proteins in E. coli is reduced after several generations in exponential growth.

Shachrai I, Zaslaver A, Alon U, Dekel E.

Mol Cell. 2010 Jun 11;38(5):758-67. doi: 10.1016/j.molcel.2010.04.015. Epub 2010 Apr 29. Erratum in: Mol Cell. 2011 May 6;42(3):401.

25.

Protein dynamics in drug combinations: a linear superposition of individual-drug responses.

Geva-Zatorsky N, Dekel E, Cohen AA, Danon T, Cohen L, Alon U.

Cell. 2010 Mar 5;140(5):643-51. doi: 10.1016/j.cell.2010.02.011.

26.

Invariant distribution of promoter activities in Escherichia coli.

Zaslaver A, Kaplan S, Bren A, Jinich A, Mayo A, Dekel E, Alon U, Itzkovitz S.

PLoS Comput Biol. 2009 Oct;5(10):e1000545. doi: 10.1371/journal.pcbi.1000545. Epub 2009 Oct 23.

27.

Adaptive prediction of environmental changes by microorganisms.

Mitchell A, Romano GH, Groisman B, Yona A, Dekel E, Kupiec M, Dahan O, Pilpel Y.

Nature. 2009 Jul 9;460(7252):220-4. doi: 10.1038/nature08112. Epub 2009 Jun 17.

PMID:
19536156
28.

Extinctions in heterogeneous environments and the evolution of modularity.

Kashtan N, Parter M, Dekel E, Mayo AE, Alon U.

Evolution. 2009 Aug;63(8):1964-75. doi: 10.1111/j.1558-5646.2009.00684.x. Epub 2009 Mar 10.

29.

Microbial growth inhibition by alternating electric fields.

Giladi M, Porat Y, Blatt A, Wasserman Y, Kirson ED, Dekel E, Palti Y.

Antimicrob Agents Chemother. 2008 Oct;52(10):3517-22. doi: 10.1128/AAC.00673-08. Epub 2008 Jul 28.

30.

The incoherent feed-forward loop can generate non-monotonic input functions for genes.

Kaplan S, Bren A, Dekel E, Alon U.

Mol Syst Biol. 2008;4:203. doi: 10.1038/msb.2008.43. Epub 2008 Jul 15.

31.

Defined order of evolutionary adaptations: experimental evidence.

Oxman E, Alon U, Dekel E.

Evolution. 2008 Jul;62(7):1547-54. doi: 10.1111/j.1558-5646.2008.00397.x.

PMID:
18410537
32.

Diverse two-dimensional input functions control bacterial sugar genes.

Kaplan S, Bren A, Zaslaver A, Dekel E, Alon U.

Mol Cell. 2008 Mar 28;29(6):786-92. doi: 10.1016/j.molcel.2008.01.021.

33.

Cost-benefit theory and optimal design of gene regulation functions.

Kalisky T, Dekel E, Alon U.

Phys Biol. 2007 Nov 7;4(4):229-45.

PMID:
17991990
34.

Alternating electric fields arrest cell proliferation in animal tumor models and human brain tumors.

Kirson ED, DbalĂ˝ V, Tovarys F, Vymazal J, Soustiel JF, Itzhaki A, Mordechovich D, Steinberg-Shapira S, Gurvich Z, Schneiderman R, Wasserman Y, Salzberg M, Ryffel B, Goldsher D, Dekel E, Palti Y.

Proc Natl Acad Sci U S A. 2007 Jun 12;104(24):10152-7. Epub 2007 Jun 5.

35.

Oscillations and variability in the p53 system.

Geva-Zatorsky N, Rosenfeld N, Itzkovitz S, Milo R, Sigal A, Dekel E, Yarnitzky T, Liron Y, Polak P, Lahav G, Alon U.

Mol Syst Biol. 2006;2:2006.0033. Epub 2006 Jun 13.

36.

Rules for biological regulation based on error minimization.

Shinar G, Dekel E, Tlusty T, Alon U.

Proc Natl Acad Sci U S A. 2006 Mar 14;103(11):3999-4004. Epub 2006 Mar 6.

37.

Environmental selection of the feed-forward loop circuit in gene-regulation networks.

Dekel E, Mangan S, Alon U.

Phys Biol. 2005 Jun;2(2):81-8.

PMID:
16204860
38.

Optimality and evolutionary tuning of the expression level of a protein.

Dekel E, Alon U.

Nature. 2005 Jul 28;436(7050):588-92.

PMID:
16049495
39.

Disruption of cancer cell replication by alternating electric fields.

Kirson ED, Gurvich Z, Schneiderman R, Dekel E, Itzhaki A, Wasserman Y, Schatzberger R, Palti Y.

Cancer Res. 2004 May 1;64(9):3288-95.

40.

Analyses of p53 expression pattern and BRCA mutations in patients with double primary breast and ovarian cancer.

Bruchim I, Fishman A, Friedman E, Goldberg I, Chetrit A, Barshack I, Dekel E, Hirsh-Yechezkel G, Modan B, Kopolovic J.

Int J Gynecol Cancer. 2004 Mar-Apr;14(2):251-8.

PMID:
15086724
41.

Patients with double primary tumors in the breast and ovary- clinical characteristics and BRCA1-2 mutations status.

Fishman A, Dekel E, Chetrit A, Lerner-Geva L, Bar-Am A, Beck D, Beller U, Ben-Baruch G, Piura B, Friedman E, Struewing JP, Modan B.

Gynecol Oncol. 2000 Oct;79(1):74-8.

PMID:
11006035

Supplemental Content

Support Center